.Just 5 months after safeguarding a $100 thousand IPO, Vast Bio is actually giving up some workers a...
.The initial stages of oncology R&D may not be except interesting new methods, as well as Halda T...
.Psychopharmacology has taken three write-ups about midstage clinical trial data analyzing Lykos The...
.Avidity Biosciences impressed entrepreneurs with phase 1/2 data in Duchenne muscle dystrophy (DMD) ...
.Actinogen Medical's cortisol blocker has missed out on the main endpoint of a phase 2 research in d...
.Antibody-drug conjugates (ADCs) have been at the center of many a billion-dollar biobuck licensing ...
.Property manager TPG, which has sustained biotechs like Sionna Rehabs as well as Santa Ana Bio, has...
.Merck & Co.'s TIGIT plan has experienced yet another trouble. Months after shuttering a period 3...
.After a year determined by pipeline hairstyles, the departure of its CEO and also cutbacks, Exscien...
.Cullinan Therapeutics was made an impression on good enough with Port BioMed's bispecific immune re...